Tranexamic Acid Pill

Phase 3Small molecule

HHenry Ford Health System

Tranexamic Acid Pill is one of 7 small molecule programs targeting Tranexamic Acid. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Tranexamic AcidActive, not recruiting

Tranexamic AcidPhase 3

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Tranexamic Acid

#DrugCompanyPhaseTrials

Cyklokapron

JJ Molner

Approved

156 2

Pitressin

AAultman Health Foundation

Approved

3 3

Tranexamic Acid Pill

HHenry Ford Health System

Phase 3

1 4

IV TXA

MMassachusetts General Hospital

Phase 3

1 5

Adrenaline

AARS Pharmaceuticals, Inc.

Preclinical

2 6

IV Atropine

AAssiut University

Preclinical

1 7

Progynova

UUniversitair Ziekenhuis Brussel

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hip Fracture1 trial

Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures

Withdrawn·HHenry Ford Health System·Phase 3·NCT05518279

Tranexamic Acid1 trial

Extended Postoperative Oral Tranexamic Acid in Knee Replacement

Active, not recruiting·CCampbell Clinic·Phase 4·NCT05099276·46 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Tranexamic Acid Pill. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tranexamic Acid Pill compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tranexamic Acid Pill. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Henry Ford Health System company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: HHenry Ford Health System

Tranexamic Acid Pill

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hip Fracture1 trial

Tranexamic Acid1 trial

References

Drug Info

Quick Facts

Related News